Abstract |
2 |
Table of Contents |
2 |
Take‐Home Messages |
4 |
Section 1 Introduction |
4 |
1.1 |
Preamble |
4 |
1.2 |
Document scope and rationale |
4 |
1.3 |
Editorial independence |
5 |
1.4 |
Organization of the writing committee |
5 |
1.5 |
Evidence review and formulation of recommendation |
5 |
1.6 |
Class of recommendation and level of evidence |
6 |
1.7 |
Document review and approval |
6 |
1.8 |
Document updates |
7 |
1.9 |
Relevant clinical practice |
7 |
Section 2 General concepts |
7 |
2.1 |
Definitions |
7 |
2.2 |
Remote monitoring considerations |
8 |
|
Synopsis |
8 |
|
Recommendation‐specific supportive text |
9 |
2.3 |
Remote monitoring payment/reimbursement models |
9 |
|
Synopsis |
9 |
|
Recommendation‐specific supportive text |
10 |
Section 3 Administrative and nonclinical staff |
10 |
3.1 |
Patient enrollment techniques |
10 |
|
Synopsis |
10 |
|
Recommendation‐specific supportive text |
10 |
3.2 |
Managing and updating manufacturer websites |
11 |
|
Synopsis |
11 |
|
Recommendation‐specific supportive text |
11 |
3.3 |
Techniques to optimize patient connectivity |
11 |
|
Synopsis |
11 |
|
Recommendation‐specific supportive text |
11 |
Section 4 Staffing of remote monitoring clinics |
11 |
4.1 |
Recommended staffing requirements for remote monitoring |
12 |
|
Synopsis |
12 |
4.2 |
Staff credentialing and qualifications for remote monitoring |
15 |
|
Synopsis |
15 |
|
Recommendation‐specific supportive text |
15 |
Section 5 Technical considerations in remote monitoring |
15 |
5.1 |
Devices with noncontinuous remote monitoring |
16 |
|
Synopsis |
16 |
|
Recommendation‐specific supportive text |
16 |
5.2 |
Site‐based remote monitoring |
16 |
|
Synopsis |
16 |
|
Recommendation‐specific supportive text |
18 |
Section 6 Alert‐based remote monitoring |
18 |
|
Synopsis |
19 |
|
Recommendation‐specific supportive text |
19 |
Section 7 Programming considerations for optimal remote monitoring |
19 |
7.1 |
Manufacturer and device‐specific knowledge |
20 |
|
Synopsis |
20 |
|
Recommendation‐specific supportive text |
20 |
7.2 |
Programming for clinical indications with different types of cardiovascular implantable electronic devices |
20 |
|
Synopsis |
21 |
|
Recommendation‐specific supportive text |
21 |
7.3 |
Special programming considerations for implantable loop recorders |
23 |
|
Synopsis |
23 |
|
Recommendation‐specific supportive text |
24 |
Section 8 Managing alerts |
25 |
8.1 |
Defining high‐priority alerts |
25 |
|
Synopsis |
25 |
|
Recommendation‐specific supportive text |
25 |
8.2 |
Programming considerations to minimize inappropriate alerts |
27 |
|
Synopsis |
27 |
|
Recommendation‐specific supportive text |
27 |
8.3 |
Timeline recommendations for alert management |
27 |
|
Synopsis |
27 |
|
Recommendation‐specific supportive text |
27 |
Section 9 Remote monitoring reporting |
28 |
9.1 |
Communication of the remote monitoring report to patients |
28 |
|
Synopsis |
29 |
|
Recommendation‐specific supportive text |
29 |
9.2 |
Components of a comprehensive report |
29 |
9.3 |
Techniques for incorporating reports into electronic health records |
29 |
|
Synopsis |
29 |
|
Recommendation‐specific supportive text |
29 |
Section 10 Patient education for remote monitoring |
31 |
10.1 |
Patient education for participation and compliance |
31 |
|
Synopsis |
31 |
|
Recommendation‐specific supportive text |
32 |
10.2 |
Patient education of clinic‐specific policies |
33 |
|
Synopsis |
33 |
|
Recommendation‐specific supportive text |
33 |
Section 11 Manufacturer responsibilities with remote monitoring |
33 |
11.1 |
Manufacturers’ role to optimize individual patient care |
33 |
|
Synopsis |
34 |
|
Recommendation‐specific supportive text |
34 |
11.2 |
Manufacturers’ role in the management of patient safety advisories via remote monitoring |
34 |
|
Synopsis |
35 |
|
Recommendation‐specific supportive text |
35 |
11.3 |
Support surrounding implantation from manufacturers |
35 |
|
Synopsis |
35 |
|
Recommendation‐specific supportive text |
36 |
Section 12 Third‐party resources for remote monitoring |
36 |
12.1 |
Use of third‐party resources in remote monitoring |
36 |
|
Synopsis |
36 |
|
Recommendation‐specific supportive text |
37 |
Section 13 Pediatric considerations with remote monitoring |
37 |
Section 14 Geographic differences with remote monitoring practices |
38 |
14.1 |
Availability of remote monitoring |
38 |
|
Synopsis |
38 |
|
Recommendation‐specific supportive text |
38 |
Section 15 Knowledge gaps and future needs |
38 |
15.1 |
Remote monitoring can “shorten” large geographic distances |
38 |
15.2 |
Remote programming |
38 |
15.3 |
Inequitable access to cardiovascular implantable electronic device remote monitoring |
39 |
15.4 |
Reimbursement reform for remote monitoring |
39 |
15.5 |
Better information, not more information |
39 |
15.6 |
Direct patient access to device information |
40 |
15.7 |
Summary: Further research about remote monitoring |
40 |
15.8 |
Summary: Past, present, and future |
40 |
|
References |
40 |
|
Appendix |
48 |